SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-03-000412
Filing Date
2003-01-27
Accepted
2003-01-27 15:09:16
Documents
3
Period of Report
2003-01-23
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b45347age8vk.txt 8-K 5147
3 UNDERWRITING AGREEMENT 01/23/03 b45347agexv1w3.txt EX-1.3 130244
4 OPINION OF ROPES & GRAY b45347agexv5w3.txt EX-5.3 2735
  Complete submission text file 0000950135-03-000412.txt   139976
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 03525754
SIC: 2836 Biological Products, (No Diagnostic Substances)